Congratulations to our portfolio company Echo on their acquisition by CELLINK!

We’ve been investing in our thesis of TechBio for five years, so let’s take a look at how we’re doing…

Watch our CEO, Neil Littman, share the story that inspired him to found Bioverge.

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.

A brief explanation of the importance of diversification in and the unique characteristics of healthcare venture capital investment.

Angel Investing defined: A basic guide to help individual investors understand this new opportunity.

Even in our modern age of medical miracles, the prognosis and treatments for end-stage organ failure are still woefully inadequate. IVIVA Medical is on course to change all that.

Over 23 million Americans suffer from disorders that stem from their immune systems mistakenly attacking their own, healthy cells. Octagon offers revolutionary treatments for these autoimmune diseases without compromising healthy immune function.